| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bf7439808d578ab8c3698f7560fe4ab |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-25375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-25125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-105831
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-106664
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-967 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3679
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 |
| filingDate |
2007-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bdb84882eef28d1cd9b4c6a64f25691
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd06ca466a7fb1fe057c8ded3ec9453d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc56deaa882c36b7ab28b3d8337b7c09 |
| publicationDate |
2007-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007092625-A2 |
| titleOfInvention |
Prevention and treatment of atherosclerosis by reducing carbamylation of ldl or the effects of cldl |
| abstract |
The present invention provides a method to decrease the level of cLDL by direct elimination of cLDL from the blood or plasma of an individual. Also provided is a method of reducing carbamylation in an individual with a monomeric amino acid or other enzymatic or non-enzymatic inhibitors of carbamylation. In addition the present invention provides a method of determining whether an individual is at risk for atherosclerosis, comprising the step of measuring the level of cLDL and/or autoantibody to cLDL in a sample obtained from this individual. The present invention further provides a method of treating or preventing atherosclerosis in an individual by inhibiting aggregation and/or deposition of cLDL in the individual. |
| priorityDate |
2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |